Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Mohanad Al-Obaidi
Assistant Clinical Professor, Medicine - (Clinical Series Track)
Medicine
Overview
Research
More
Collaboration
(12)
Joshua Malo
Mutual work: 1 Grant
Collaboration Details
Tirdad Zangeneh
Mutual work: 16 Publications﹒2 Grants
Collaboration Details
Edward Bedrick
Mutual work: 2 Publications
Collaboration Details
Aneesha Shetty
Mutual work: 2 Publications
Collaboration Details
Pooja Rangan
Mutual work: 2 Publications
Collaboration Details
Page 1 of 3
Previous page
Next page
Grants
(3)
A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus
Active
·
2023
·
$973.3K / $243.3K
·
External
Principal Investigator (PI)
candidemia,
invasive candidiasis,
treatment regimens,
echinocandin,
ibrexafungerp
Improved Serological Diagnosis of Coccidiodomycosis
Active
·
2023
·
$444.3K / $74K
·
External
Principal Investigator (PI)
diagnostic methods,
infectious diseases,
serological testing,
fungal infections,
medical mycology
A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection versus Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down in the...
2019
·
$258.2K
·
External
Principal Investigator (PI)
antifungal,
clinical trial,
efficacy,
safety,
intravenous administration
Publications
(29)
Recent
Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
2023
antifungal prescription,
medicare part d,
provider utilization,
payment data analysis,
trends
Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region
2023
antifungal susceptibility,
coccidioides species,
healthcare system,
endemic region,
testing experience
Effect of coccidioidomycosis prophylaxis in selecting non‐Candida albicans species amongst solid organ transplant recipients in Arizona
2023
coccidioidomycosis,
prophylaxis,
solid organ transplant,
non‐candida albicans species,
arizona
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated era
2023
monoclonal antibody,
sars-cov-2 omicron,
high-risk patients,
viral subvariants,
antibody effectiveness
Race and ethnicity: Risk factors for fungal infections?
2023
Diagnostic Approach to Coccidioidomycosis in Solid Organ Transplant Recipients
2023
coccidioidomycosis,
solid organ transplant,
diagnostic approach
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis ReSTORE) a multicentre, double-blind, double-dummy, randomised phase 3 trial
2023
The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab Evusheld) Real-World Experience at a Large Academic Center
2023
covid-19,
prevention,
high-risk patients,
tixagevimab-cilgavimab,
real-world experience
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant Era
2023
covid-19,
antiviral,
hospitalizations,
high-risk patients,
omicron variant
The Utility of 1→3)β-D-Glucan Testing in the Diagnosis of Coccidioidomycosis in Hospitalized Immunocompromised Patients
2022
coccidioidomycosis,
immunocompromised,
diagnostic testing,
1→3)β-d-glucan,
hospitalized patients